Global X Genomics & Biotechnology ETF (GNOM) Short Interest Ratio & Short Volume $9.65 -0.55 (-5.39%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Global X Genomics & Biotechnology ETF Short Interest DataGlobal X Genomics & Biotechnology ETF (GNOM) has a short interest of 13,400 shares. This marks a -21.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 57,130 shares to cover all short positions.Current Short Interest13,400 sharesPrevious Short Interest17,000 sharesChange Vs. Previous Month-21.18%Dollar Volume Sold Short$139,092.00Short Interest Ratio0.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares7,310,000 sharesPercentage of Shares Shorted0.18%Today's Trading Volume81,908 sharesAverage Trading Volume57,130 sharesToday's Volume Vs. Average143% Short Selling Global X Genomics & Biotechnology ETF? Sign up to receive the latest short interest report for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNOM Short Interest Over TimeGNOM Days to Cover Over TimeGNOM Percentage of Float Shorted Over Time Ad Golden CrestBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide Global X Genomics & Biotechnology ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202413,400 shares $139,092.00 -21.2%N/A0.3 $10.38 10/15/202417,000 shares $186,660.00 -7.1%N/A0.4 $10.98 9/30/202418,300 shares $205,875.00 +21.2%N/A0.3 $11.25 9/15/202415,100 shares $171,243.06 -41.5%N/A0.3 $11.34 8/31/202425,800 shares $293,604.00 +6.6%N/A0.5 $11.38 8/15/202424,200 shares $273,387.40 +70.4%N/A0.4 $11.30 Get the Latest News and Ratings for GNOM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Global X Genomics & Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. 7/31/202414,200 shares $165,146.00 -10.1%N/A0.3 $11.63 7/15/202415,800 shares $179,646.00 +47.7%N/A0.3 $11.37 6/30/202410,700 shares $111,708.00 -32.7%N/A0.2 $10.44 6/15/202415,900 shares $166,314.00 +62.2%N/A0.3 $10.46 5/31/20249,800 shares $99,470.00 -31.9%N/A0.2 $10.15 5/15/202414,400 shares $157,248.00 -22.6%N/A0.2 $10.92 4/30/202418,600 shares $183,210.00 +69.1%N/A0.2 $9.85 4/15/202411,000 shares $112,750.00 No ChangeN/A0.1 $10.25 3/31/202411,000 shares $125,180.00 -77.9%N/A0.2 $11.38 3/15/202449,800 shares $571,206.00 -12.0%N/A0.7 $11.47 2/29/202456,600 shares $678,068.00 +133.9%N/A0.7 $11.98 2/15/202424,200 shares $276,848.00 +15.8%N/A0.4 $11.44 1/31/202420,900 shares $224,675.00 -20.8%N/A0.3 $10.75 1/15/202426,400 shares $299,376.00 +80.8%N/A0.1 $11.34 12/31/202314,600 shares $168,748.26 -9.9%N/A0.1 $11.56 12/15/202316,200 shares $183,546.00 -61.6%N/A0.1 $11.33 11/30/202342,200 shares $439,724.00 +47.6%N/A0.1 $10.42 11/15/202328,600 shares $287,716.00 -41.3%N/A0.1 $10.06 10/31/202348,700 shares $430,995.00 -28.5%N/A0.2 $8.85 10/15/202368,100 shares $661,932.00 -14.8%N/A0.3 $9.72 9/30/202379,900 shares $812,583.00 +415.5%N/A0.4 $10.17 9/15/202315,500 shares $168,795.00 -95.9%N/A0.1 $10.89 8/31/2023374,700 shares $4.21 million +4,963.5%N/A3.5 $11.23 8/15/20237,400 shares $82,880.00 -54.9%N/A0.1 $11.20 7/31/202316,400 shares $201,228.00 -64.7%N/A0.2 $12.27 7/15/202346,400 shares $568,864.00 -32.0%N/A0.8 $12.26 6/30/202368,200 shares $826,584.00 +44.8%N/A0.9 $12.12 6/15/202347,100 shares $607,590.00 -32.2%N/A0.6 $12.90 5/31/202369,500 shares $849,290.00 +100.9%N/A0.8 $12.22 5/15/202334,600 shares $452,222.00 +16.1%N/A0.4 $13.07 4/30/202329,800 shares $365,348.00 -60.5%N/A0.3 $12.26 4/15/202375,400 shares $944,762.00 -26.7%N/A0.8 $12.53 3/31/2023102,800 shares $1.27 million +139.6%N/A1.1 $12.32 3/15/202342,900 shares $526,383.00 +29.2%N/A0.5 $12.27Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide 2/28/202333,200 shares $419,316.00 -61.4%N/A0.3 $12.63 2/15/202386,100 shares $1.14 million -13.3%N/A0.9 $13.29 1/31/202399,300 shares $1.35 million -23.7%N/A1 $13.58 1/15/2023130,200 shares $1.77 million +45.0%N/A1.3 $13.60 12/30/202289,800 shares $1.14 million -15.1%N/A0.8 $12.65 12/15/2022105,800 shares $1.39 million +63.8%N/A1 $13.09 11/30/202264,600 shares $872,100.00 +36.6%N/A0.7 $13.50 11/15/202247,300 shares $648,956.00 +48.3%N/A0.5 $13.72 10/31/202231,900 shares $419,485.00 -55.8%N/A0.3 $13.15 10/15/202272,100 shares $876,015.00 No ChangeN/A0.7 $12.15 9/30/2022110,000 shares $1.38 million -60.7%N/A1 $12.55 9/15/2022279,900 shares $3.97 million +232.0%N/A2.2 $14.19 8/31/202284,300 shares $1.17 million -43.7%N/A0.6 $13.83 8/15/2022149,800 shares $2.44 million +22.0%N/A1.1 $16.28 7/31/2022122,800 shares $1.75 million -25.3%N/A0.6 $14.24 7/15/2022164,400 shares $2.32 million -23.2%N/A0.8 $14.09 6/30/2022214,100 shares $2.62 million +237.2%N/A1.1 $12.22 6/15/202263,500 shares $706,120.00 +56.0%N/A0.4 $11.12 5/31/202240,700 shares $488,400.00 +2.8%N/A0.3 $12.00 5/15/202239,600 shares $467,676.00 -44.2%N/A0.2 $11.81 4/30/202271,000 shares $904,540.00 +30.3%N/A0.7 $12.74 4/15/202254,500 shares $790,250.00 +16.2%N/A0.5 $14.50 3/31/202246,900 shares $704,907.00 -1.3%N/A0.4 $15.03 3/15/202247,500 shares $644,100.00 -57.7%N/A0.3 $13.56 2/28/2022112,300 shares $1.74 million +18.7%N/A0.8 $15.46 2/15/202294,600 shares $1.54 million -0.9%N/A0.7 $16.31 1/31/202295,500 shares $1.54 million +41.3%N/A0.7 $16.14 1/15/202267,600 shares $1.16 million -18.5%N/A0.5 $17.22 12/31/202182,900 shares $1.65 million +18.8%N/A0.7 $19.85 12/15/202169,800 shares $1.42 million -30.8%N/A0.7 $20.38 11/30/2021100,800 shares $2.08 million +72.9%N/A1.1 $20.62 11/15/202158,300 shares $1.23 million -20.6%N/A0.6 $21.02 10/29/202173,400 shares $1.57 million +1.4%N/A0.9 $21.43 10/15/202172,400 shares $1.55 million +11.9%N/A0.9 $21.46 9/30/202164,700 shares $1.43 million -55.8%N/A0.8 $22.14 9/15/2021146,200 shares $3.43 million +56.5%N/A1.6 $23.46 8/31/202193,400 shares $2.25 million -31.2%N/A1 $24.12 8/13/2021135,700 shares $3.12 million +18.8%N/A1.5 $22.98 7/30/2021114,200 shares $2.62 million +13.0%N/A1.3 $22.93 7/15/2021101,100 shares $2.29 million -14.7%N/A1.1 $22.64 6/30/2021118,500 shares $2.95 million -4.1%N/A1.2 $24.89 6/15/2021123,500 shares $2.82 million +17.6%N/A1.1 $22.83 5/28/2021105,000 shares $2.26 million -48.8%N/A1 $21.50 5/14/2021205,000 shares $4.05 million +42.7%N/A1.6 $19.75 4/30/2021143,700 shares $3.29 million -30.7%N/A0.9 $22.87 4/15/2021207,300 shares $4.67 million +33.1%N/A1.3 $22.55 3/31/2021155,800 shares $3.34 million -4.3%N/A0.9 $21.44 3/15/2021162,800 shares $3.82 million +59.9%N/A0.9 $23.45 2/26/2021101,800 shares $2.42 million -75.1%N/A0.6 $23.77 2/12/2021408,900 shares $11.23 million +228.2%N/A2.8 $27.47Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?Click Here For Your Free Guide 1/29/2021124,600 shares $3.12 million -15.4%N/A1.1 $25.07 1/15/2021147,300 shares $3.88 million No ChangeN/A1.6 $26.32 GNOM Short Interest - Frequently Asked Questions What is Global X Genomics & Biotechnology ETF's current short interest? Short interest is the volume of Global X Genomics & Biotechnology ETF shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 13,400 shares of GNOM short. Learn More on Global X Genomics & Biotechnology ETF's current short interest. Is Global X Genomics & Biotechnology ETF's short interest increasing or decreasing? Global X Genomics & Biotechnology ETF saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 13,400 shares, a drop of 21.2% from the previous total of 17,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Global X Genomics & Biotechnology ETF's short interest compare to its competitors? Here is how the short interest of companies compare to Global X Genomics & Biotechnology ETF: Tema Cardiovascular and Metabolics ETF (0.02%), CrossingBridge Pre-Merger SPAC ETF (0.18%), iShares ESG Advanced MSCI EM ETF (0.10%), Tradr 2X Short Innovation Daily ETF (30.87%), Fidelity Disruptors ETF (0.00%), Global X Aging Population ETF (0.06%), Siren Nasdaq NexGen Economy ETF (0.16%), Invesco ESG NASDAQ 100 ETF (1.49%), REX AI Equity Premium Income ETF (1.61%), Tradr 2X Long Innovation ETF (6.11%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Global X Genomics & Biotechnology ETF stock? Short selling GNOM is an investing strategy that aims to generate trading profit from Global X Genomics & Biotechnology ETF as its price is falling. GNOM shares are trading down $0.55 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Global X Genomics & Biotechnology ETF? A short squeeze for Global X Genomics & Biotechnology ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNOM, which in turn drives the price of the stock up even further. How often is Global X Genomics & Biotechnology ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNOM, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Tema Cardiovascular and Metabolics ETF Short Squeeze CrossingBridge Pre-Merger SPAC ETF Short Squeeze iShares ESG Advanced MSCI EM ETF Short Squeeze Tradr 2X Short Innovation Daily ETF Short Squeeze Fidelity Disruptors ETF Short Squeeze Global X Aging Population ETF Short Squeeze Siren Nasdaq NexGen Economy ETF Short Squeeze Invesco ESG NASDAQ 100 ETF Short Squeeze REX AI Equity Premium Income ETF Short Squeeze Tradr 2X Long Innovation ETF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNOM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Genomics & Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Genomics & Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNOM Stock Alerts